← Back to Search

Behavioural Intervention

Multidisciplinary Care for Brain Metastases

N/A

Recruiting

Research Sponsored by University of Vermont Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must be able to complete questionnaires in English

Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-12 months

Awards & highlights

Study Summary

This trial is looking at whether intensive multi-disciplinary care for patients with brain metastases is better than standard care at improving patient-reported symptoms and their awareness of their prognosis.

Who is the study for?

This clinical trial is for patients with brain metastases, which are cancerous tumors that have spread to the brain. Participants should be those who require a new approach to care and are currently receiving standard treatment.Check my eligibility

What is being tested?

The study is testing whether an intensive multi-disciplinary care approach can improve patient-reported symptoms and awareness of their prognosis compared to standard care in individuals with brain metastases.See study design

What are the potential side effects?

Since this is a health services intervention, it does not involve drugs or medical procedures, so traditional side effects are not expected. However, changes in care may affect emotional well-being or stress levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can complete questionnaires in English.

Select...

I have been newly diagnosed with brain metastases from a solid tumor.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient reported outcomes

Secondary outcome measures

Feasibility

Patient understanding of prognosis

survival

Other outcome measures

Exploratory survival outcome

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Multidisciplinary CareExperimental Treatment1 Intervention

Group II: Standard of CareActive Control1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Vermont Medical CenterLead Sponsor

41 Previous Clinical Trials

25,785 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"Indeed, the information from clinicaltrials.gov highlights that this trial is presently in search of eligible participants. The initial posting date for this study was November 16th, 2023, with the most recent update occurring on February 19th, 2024. Recruitment targets include enrolling 40 patients at a single designated site."

Answered by AI

What is the current number of participants being admitted into this research trial?

"Indeed, the details provided on clinicaltrials.gov affirm that this investigation is actively seeking participants. The trial was initially published on November 16th, 2023, and underwent its latest update on February 19th, 2024. Enrollment aims to secure 40 patients from a singular location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Multi-disciplinary Care for Brain Metastases

Alissa Thomas 2023. "Multi-disciplinary Care for Brain Metastases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06280300.